Strategic Network TRIO-US is an SMO with a network of over 15 community oncology practices across multiple states, affiliated with UCLA JCCC. This presents a clear opportunity to offer services that enhance multi-site trial readiness, site management, and translational research capabilities for faster study activation and broadened trial access.

Clinical Research Focus Specialization in translational oncology research and long-standing participation in trials for over 20 years indicate established trial workflow, data capture, and regulatory processes. Potential upsell areas include advanced trial management platforms, patient recruitment optimization, and translational data services.

Tech Enablement Tech stack includes OpenAI, iCIMS, and cloud-based collaboration tools, suggesting openness to tech-enhanced patient recruitment, data analytics, and automated outreach. Opportunities exist to offer AI-powered patient matching, sponsor reporting dashboards, and integrated site portals.

Resource Profile Small to mid-sized network (11-50 employees per site, network-wide breadth across states) implies resource constraints and reliance on scalable, cost-effective solutions such as outsourced regulatory support, centralized data management, or modular services that can grow with the network.

Funding Signal Revenue range ($1M-$10M) signals growth and potential appetite for affordable, value-driven partnerships, pilot programs, or tiered service offerings. Approach can emphasize ROI through improved trial activation timelines, patient enrollment efficiency, and sponsor satisfaction metrics.